Cancel
See Linkedin
Known information
- Has over two decades of experience in the design, development, and manufacturing of small molecule and oligonucleotide therapeutics
- Served as the Vice President and Head of Oligonucleotide and Small Molecule Development at Biogen
- Earned his B.S. and Ph.D. in chemistry from the University of Connecticut
- Pursued his postdoctoral research at Duke University
- Co-author on more than 40 publications and patents
- Contributed to five book chapters
About Alltrna
Alltrna is the world's first tRNA platform company, pioneering tRNA therapeutics to potentially treat thousands of diseases by targeting premature stop codons.
Report inaccurate information
